FAMDFFutura Medical Plc

About Futura Medical Plc (FAMDF)

Futura Medical Plc (FAMDF) is a Biotechnology company headquartered in Guildford, United Kingdom whose shares trade over-the-counter on the Pink tier.

Futura Medical is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation for the prescription and consumer healthcare in sexual health and pain relief. Co. is engaged in the development of transdermal technology platform, DermaSys® for the absorption of active molecules through the skin. Through its DermaSys® technology, Co is in the progress of the development and regulatory approval for MED3000, a treatment for erectile dysfunction; and TPR100, a topical non-steroidal anti-inflammatory diclofenac pain relief gel for the pain and inflammation associated with sprains, strains, bruises and soft tissue rheumatism.

FAMDF key facts

Ticker symbol

FAMDF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Guildford, United Kingdom

Country of incorporation

GB

Estimated market cap

$40.66M (as of Apr 11, 2025)

Shares outstanding

271,046,179

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Not Available

Fiscal year end

12/31

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with F